Theolytics’ Innovative Approach to Cancer: Oncolytic Viruses and Real Patient Data at the Forefront
Oxford-based biotech company Theolytics is pioneering a new frontier in cancer treatment by harnessing the power of oncolytic viruses to selectively target tumours while sparing healthy tissue.